1379 related articles for article (PubMed ID: 24217192)
21. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Kurinij N; Davis MD;
Ophthalmology; 2013 Aug; 120(8):1604-11.e4. PubMed ID: 23582353
[TBL] [Abstract][Full Text] [Related]
22. Nutritional supplementation and age-related macular degeneration.
Olson JH; Erie JC; Bakri SJ
Semin Ophthalmol; 2011 May; 26(3):131-6. PubMed ID: 21609225
[TBL] [Abstract][Full Text] [Related]
23. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
Young M; Chui L; Fallah N; Or C; Merkur AB; Kirker AW; Albiani DA; Forooghian F
Retina; 2014 Jul; 34(7):1308-15. PubMed ID: 24451923
[TBL] [Abstract][Full Text] [Related]
24. Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.
Tolentino MJ; Dennrick A; John E; Tolentino MS
Expert Opin Investig Drugs; 2015 Feb; 24(2):183-99. PubMed ID: 25243494
[TBL] [Abstract][Full Text] [Related]
25. Evidence-based nutritional advice for patients affected by age-related macular degeneration.
Andreatta W; El-Sherbiny S
Ophthalmologica; 2014; 231(4):185-90. PubMed ID: 24821294
[TBL] [Abstract][Full Text] [Related]
26. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Aronow ME; Chew EY
Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
[TBL] [Abstract][Full Text] [Related]
27. Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors.
Camelo S; Latil M; Veillet S; Dilda PJ; Lafont R
Oxid Med Cell Longev; 2020; 2020():4984927. PubMed ID: 33520083
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2012 Jun; (6):CD000253. PubMed ID: 22696317
[TBL] [Abstract][Full Text] [Related]
29. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.
Bressler NM; Bressler SB; Congdon NG; Ferris FL; Friedman DS; Klein R; Lindblad AS; Milton RC; Seddon JM;
Arch Ophthalmol; 2003 Nov; 121(11):1621-4. PubMed ID: 14609922
[TBL] [Abstract][Full Text] [Related]
30. [Nutrition and age-related macular degeneration].
Desmettre T; Lecerf JM; Souied EH
J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S38-56. PubMed ID: 15602406
[TBL] [Abstract][Full Text] [Related]
31. Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials?
Chew EY
Ophthalmologica; 2017; 238(1-2):1-5. PubMed ID: 28478452
[TBL] [Abstract][Full Text] [Related]
32. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
; Papudesu C; Clemons TE; Agrón E; Chew EY
Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
[TBL] [Abstract][Full Text] [Related]
33. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
[TBL] [Abstract][Full Text] [Related]
34. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.
Finger RP; Guymer RH; Gillies MC; Keeffe JE
Ophthalmology; 2014 Jun; 121(6):1246-51. PubMed ID: 24518613
[TBL] [Abstract][Full Text] [Related]
35. Age related macular degeneration--should your patients be taking additional supplements?
Jones AA
Aust Fam Physician; 2007 Dec; 36(12):1026-8. PubMed ID: 18075628
[TBL] [Abstract][Full Text] [Related]
36. Dietary Intakes of Eicosapentaenoic Acid and Docosahexaenoic Acid and Risk of Age-Related Macular Degeneration.
Wu J; Cho E; Giovannucci EL; Rosner BA; Sastry SM; Willett WC; Schaumberg DA
Ophthalmology; 2017 May; 124(5):634-643. PubMed ID: 28153441
[TBL] [Abstract][Full Text] [Related]
37. Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background.
Ramkumar HL; Tuo J; Shen DF; Zhang J; Cao X; Chew EY; Chan CC
J Nutr; 2013 Jul; 143(7):1129-35. PubMed ID: 23677863
[TBL] [Abstract][Full Text] [Related]
38. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
[TBL] [Abstract][Full Text] [Related]
39. Association of Dietary Nitrate and a Mediterranean Diet With Age-Related Macular Degeneration Among US Adults: The Age-Related Eye Disease Study (AREDS) and AREDS2.
Broadhead GK; Agrón E; Peprah D; Keenan TDL; Lawler TP; Mares J; Chew EY;
JAMA Ophthalmol; 2023 Feb; 141(2):130-139. PubMed ID: 36547942
[TBL] [Abstract][Full Text] [Related]
40. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study.
Ho L; van Leeuwen R; Witteman JC; van Duijn CM; Uitterlinden AG; Hofman A; de Jong PT; Vingerling JR; Klaver CC
Arch Ophthalmol; 2011 Jun; 129(6):758-66. PubMed ID: 21670343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
